These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21402723)

  • 1. A video ethnography approach to assessing the ecological validity of neurocognitive and functional measures in severe mental illness: results from a feasibility study.
    Bromley E; Mikesell L; Mates A; Smith M; Brekke JS
    Schizophr Bull; 2012 Sep; 38(5):981-91. PubMed ID: 21402723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A video ethnography approach for linking naturalistic behaviors to research constructs of neurocognition in schizophrenia.
    Bromley E; Adams GF; Brekke JS
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):125-40. PubMed ID: 22772661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of performance-based measurements of functional capacity: test-retest reliability, practice effects, and potential sensitivity to change.
    Leifker FR; Patterson TL; Bowie CR; Mausbach BT; Harvey PD
    Schizophr Res; 2010 Jun; 119(1-3):246-52. PubMed ID: 20399613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.
    Bowie CR; Leung WW; Reichenberg A; McClure MM; Patterson TL; Heaton RK; Harvey PD
    Biol Psychiatry; 2008 Mar; 63(5):505-11. PubMed ID: 17662256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia.
    Burton CZ; Vella L; Harvey PD; Patterson TL; Heaton RK; Twamley EW
    Schizophr Res; 2013 May; 146(1-3):244-8. PubMed ID: 23507359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
    Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
    Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calibration and cross-validation of MCCB and CogState in schizophrenia.
    Lees J; Applegate E; Emsley R; Lewis S; Michalopoulou P; Collier T; Lopez-Lopez C; Kapur S; Pandina GJ; Drake RJ
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3873-82. PubMed ID: 26018529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.
    Silverstein SM; Jaeger J; Donovan-Lepore AM; Wilkniss SM; Savitz A; Malinovsky I; Hawthorne D; Raines S; Carson S; Marcello S; Zukin SR; Furlong S; Dent G
    J Clin Exp Neuropsychol; 2010 Nov; 32(9):937-52. PubMed ID: 20455131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients.
    Georgiades A; Davis VG; Atkins AS; Khan A; Walker TW; Loebel A; Haig G; Hilt DC; Dunayevich E; Umbricht D; Sand M; Keefe RSE
    Schizophr Res; 2017 Dec; 190():172-179. PubMed ID: 28433500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ecologically valid performance-based social functioning assessment battery for schizophrenia.
    Shi C; He Y; Cheung EF; Yu X; Chan RC
    Psychiatry Res; 2013 Dec; 210(3):787-93. PubMed ID: 24126188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MATRICS Consensus Cognitive Battery (MCCB): performance and functional correlates.
    Lystad JU; Falkum E; Mohn C; Haaland VØ; Bull H; Evensen S; Rund BR; Ueland T
    Psychiatry Res; 2014 Dec; 220(3):1094-101. PubMed ID: 25242432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties.
    Jędrasik-Styła M; Ciołkiewicz A; Styła R; Linke M; Parnowska D; Gruszka A; Denisiuk M; Jarema M; Green MF; Wichniak A
    Psychiatr Q; 2015 Sep; 86(3):435-47. PubMed ID: 25601030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the optimal neuropsychological test battery for schizophrenia in China?
    Shi C; Kang L; Yao S; Ma Y; Li T; Liang Y; Cheng Z; Xu Y; Shi J; Xu X; Zhang C; Franklin DR; Heaton RK; Jin H; Yu X
    Schizophr Res; 2019 Jun; 208():317-323. PubMed ID: 30718121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning.
    Ventura J; Welikson T; Ered A; Subotnik KL; Keefe RSE; Hellemann GS; Nuechterlein KH
    Early Interv Psychiatry; 2020 Feb; 14(1):106-114. PubMed ID: 31183960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Brazilian standardization of the MATRICS consensus cognitive battery (MCCB): Psychometric study.
    Fonseca AO; Berberian AA; de Meneses-Gaya C; Gadelha A; Vicente MO; Nuechterlein KH; Bressan RA; Lacerda ALT
    Schizophr Res; 2017 Jul; 185():148-153. PubMed ID: 28110814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation.
    Kurtz MM; Wexler BE; Fujimoto M; Shagan DS; Seltzer JC
    Schizophr Res; 2008 Jul; 102(1-3):303-11. PubMed ID: 18495433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognition, ecological validity, and daily living in the community for individuals with schizophrenia: a mixed methods study.
    Gioia D; Brekke JS
    Psychiatry; 2009; 72(1):94-107. PubMed ID: 19366297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.